• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织型纤溶酶原激活剂与肝素用于单采程序之间中心静脉导管封管的比较

Tissue plasminogen activator vs heparin for locking central venous catheters between apheresis procedures.

作者信息

Mathur Gagan, Mott Sarah L, Collins Laura, Schlueter Annette J

机构信息

Department of Pathology, Saint Luke's Health System, Kansas City, Missouri.

Holden Comprehensive Cancer Center, University of Iowa, Iowa City, Iowa.

出版信息

J Clin Apher. 2019 Aug;34(4):445-449. doi: 10.1002/jca.21697. Epub 2019 Mar 4.

DOI:10.1002/jca.21697
PMID:30829414
Abstract

BACKGROUND

Central venous catheters (CVCs) for apheresis procedures require regular locking/flushes to maintain adequate flow rates. Literature comparing locking solutions for apheresis, where the time interval between procedures can be longer than for hemodialysis (many days to weeks), is lacking. In this study, catheter malfunction rates using recombinant tissue plasminogen activator (rt-PA) vs heparin for locking CVC between apheresis procedures were compared.

STUDY DESIGN AND METHODS

A retrospective review of 93 extracorporeal photopheresis procedures in 10 patients was performed at our institution. About 1000 U/mL heparin or 2 mg rt-PA was used as the locking solution. Heparin locks were changed at least once per week and rt-PA locks could be left in place for up to 4 weeks. Following these locks, inadequate blood flow noted on accessing CVC and/or during the procedure was scored on as: no issues, some issues, or significant issues. Binary logistic regression was used to evaluate for potential statistical difference in outcomes. Cost analysis was also performed.

RESULTS

No statistically significant difference was noted in outcomes between heparin and rt-PA lock (P value = 0.15). Total cost of heparin lock administration ($91-$362.50) was found to be more than rt-PA lock ($76) when more than one flush was needed between procedures.

CONCLUSIONS

For apheresis use, rt-PA and heparin CVC locks seem to have similar outcomes in preventing CVC malfunction. The convenience of not needing any flushes between procedures and overall cost of administering fewer locks favors rt-PA use when the interval between procedures is >7 days.

摘要

背景

用于血液分离术的中心静脉导管(CVC)需要定期封管/冲洗以维持足够的流速。目前缺乏关于血液分离术封管溶液的比较文献,血液分离术的操作间隔时间可能比血液透析更长(数天至数周)。在本研究中,比较了在血液分离术之间使用重组组织型纤溶酶原激活剂(rt-PA)与肝素封管CVC的导管故障率。

研究设计与方法

在我们机构对10例患者的93次体外光化学疗法进行了回顾性研究。使用约1000 U/mL肝素或2 mg rt-PA作为封管溶液。肝素封管每周至少更换一次,rt-PA封管可留置长达4周。在这些封管后,将在使用CVC时和/或操作过程中发现的血流不足情况分为:无问题、有一些问题或有严重问题。采用二元逻辑回归评估结果的潜在统计学差异。还进行了成本分析。

结果

肝素封管和rt-PA封管在结果上无统计学显著差异(P值 = 0.15)。当两次操作之间需要多次冲洗时,发现肝素封管的总成本(91美元至362.50美元)高于rt-PA封管(76美元)。

结论

对于血液分离术,rt-PA和肝素封管CVC在预防CVC故障方面似乎有相似的结果。当操作间隔时间>7天时,操作之间无需冲洗的便利性以及减少封管的总体成本有利于使用rt-PA。

相似文献

1
Tissue plasminogen activator vs heparin for locking central venous catheters between apheresis procedures.组织型纤溶酶原激活剂与肝素用于单采程序之间中心静脉导管封管的比较
J Clin Apher. 2019 Aug;34(4):445-449. doi: 10.1002/jca.21697. Epub 2019 Mar 4.
2
Prevention of catheter lumen occlusion with rT-PA versus heparin (Pre-CLOT): study protocol of a randomized trial [ISRCTN35253449].重组组织型纤溶酶原激活剂与肝素预防导管腔阻塞(Pre-CLOT):一项随机试验的研究方案[国际标准随机对照试验编号35253449]
BMC Nephrol. 2006 Apr 11;7:8. doi: 10.1186/1471-2369-7-8.
3
Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution.每周使用重组组织型纤溶酶原激活剂行血液透析导管封管的效果和成本。
Clin J Am Soc Nephrol. 2018 Mar 7;13(3):429-435. doi: 10.2215/CJN.08510817. Epub 2018 Jan 15.
4
Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator.用重组组织型纤溶酶原激活剂预防透析导管故障。
N Engl J Med. 2011 Jan 27;364(4):303-12. doi: 10.1056/NEJMoa1011376.
5
Citrate versus heparin lock for hemodialysis catheters: a systematic review and meta-analysis of randomized controlled trials.柠檬酸盐与肝素封管用于血液透析导管:随机对照试验的系统评价和荟萃分析。
Am J Kidney Dis. 2014 Mar;63(3):479-90. doi: 10.1053/j.ajkd.2013.08.016. Epub 2013 Oct 11.
6
Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.肝素封管液浓度与中心静脉血液透析导管故障风险
ASAIO J. 2007 Jul-Aug;53(4):485-8. doi: 10.1097/MAT.0b013e3180619519.
7
Risk factors associated with hemodialysis central venous catheter malfunction; a retrospective analysis of a randomized controlled trial.与血液透析中心静脉导管故障相关的危险因素;一项随机对照试验的回顾性分析。
Can J Kidney Health Dis. 2014 Jul 8;1:15. doi: 10.1186/2054-3581-1-15. eCollection 2014.
8
An economic evaluation of rt-PA locking solution in dialysis catheters.rt-PA 封管液用于透析导管的经济学评估。
J Am Soc Nephrol. 2014 Dec;25(12):2887-95. doi: 10.1681/ASN.2013050463. Epub 2014 Jul 10.
9
Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.用于中心静脉透析导管的4%柠檬酸钠封管溶液——肝素的一种有效且更具成本效益的替代方案。
Nephrol Dial Transplant. 2007 Feb;22(2):471-6. doi: 10.1093/ndt/gfl606. Epub 2006 Oct 25.
10
Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters.
Hemodial Int. 2007 Jan;11(1):96-8. doi: 10.1111/j.1542-4758.2007.00159.x.